Herbert Virgin - Sep 7, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP, Research & CSO
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Sep 7, 2021
Transactions value $
-$198,564
Form type
4
Date filed
9/9/2021, 04:59 PM
Previous filing
Aug 26, 2021
Next filing
Sep 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Options Exercise $6.31K +4.13K +4.14% $1.53* 104K Sep 7, 2021 Direct
transaction VIR Common Stock Sale -$67.4K -1.38K -1.32% $49.00 102K Sep 7, 2021 Direct F1
transaction VIR Common Stock Sale -$138K -2.75K -2.68% $50.00 99.7K Sep 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Options Exercise $0 -4.13K -1.54% $0.00 263K Sep 7, 2021 Common Stock 4.13K $1.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
F2 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.